Considerations to optimize and act upon long-term follow-up studies for cell and gene therapies

An interview with Elizabeth Donahue, Luis Arthur Pelloso, Dan Takefman, and Keith Wonnacott on the considerations to optimize and act upon long-term follow-up studies for cell and gene therapies.

Please enter your email to access content Read now